Understanding HoLEP - Advances in Prostate Treatment - Dr Jeevagan Murugesan

Evidence Mounts for Darolutamide Plus ADT in Hormone-Sensitive Prostate Cancer

U.S. study supports findings from a global trial using an external control arm

Erectile Dysfunction May Predispose Older Men to Multiple Types of Substance Abuse

Significantly higher risk of sedative, opioid, cocaine abuse compared with no ED diagnosis

Tibial Nerve Stimulation for Overactive Bladder Tied to Better Quality of Life

But main results from sham-controlled trial still outstanding

Prostate Cancer Drug Linked to Lower Risk of Cognitive Decline

Darolutamide offers "an option for preserving cognitive health" in advanced disease, expert says

The Blind Spot in Bladder Cancer Care: What Patients Don't Say

Patients and urologists are not always aligned on what the treatment experience will be like

In Search of Effective Treatment for Premature Ejaculation: 'I Really Have No Idea'

Lack of high-level evidence has hindered treatment development, but some patients do improve

FDA OKs Immunotherapy-BCG Combo for High-Risk Bladder Cancer

Combination significantly improved disease-free survival in phase III trial

Practice-Changing Trial in Prostate Cancer Shows Benefits of Perioperative Therapy

ADT plus apalutamide before and after surgery significantly improved metastasis-free survival

Treatment Intensification Slows Metastatic Hormone-Sensitive Prostate Cancer

Talazoparib plus enzalutamide reduces progression risk by 50% in men with DNA repair alterations

Combating Cancer-Related Fatigue: Yoga, Bupropion, Exercise Plus Methylphenidate

Significant improvement with yoga and the atypical antidepressant

FDA's 'Big Dick Energy!' Warning; UHC Retreats on Prior Auth; Nurses Beat Ebola

Health news and commentary gathered by MedPage Today staff

FDA OKs Inflatable Penile Prosthesis for Erectile Dysfunction

Appearance and performance designed to emulate a natural erection

AUA Video Pearls: Video Pearls from the American Urological Association